Matches in SemOpenAlex for { <https://semopenalex.org/work/W2964952983> ?p ?o ?g. }
- W2964952983 endingPage "1109" @default.
- W2964952983 startingPage "1109" @default.
- W2964952983 abstract "Atherosclerotic coronary artery disease (CAD) results from build-up of cholesterol-rich plaques in the walls of the coronary arteries and is a leading cause of death. Inflammation is central to atherosclerosis. Uncontrolled inflammation makes coronary plaques “unstable” and vulnerable to rupture or erosion, leading to thrombosis and myocardial infarction (MI). As multiple inflamed plaques often co-exist in the coronary system, patients are at risk of repeated atherothrombotic cardiovascular events after MI, with rates of 10–12% at one year and 18–20% at three years. This is largely because current therapies for CAD, such as lipid-lowering statins, do not adequately control plaque inflammation. New anti-atherosclerotic agents are therefore needed, especially those that better target inflammation. The recent positive results for the anti-interleukin-1-beta (IL-1β) monoclonal antibody, Canakinumab, in the Canakinumab Anti-inflammatory Thrombosis Outcome Study (CANTOS) clinical trial has provided a major stimulant to the field. It highlights that not only is inflammation important from a pathogenic and risk prediction perspective in CAD, but that reducing inflammation can be beneficial. The challenge is now to find the best strategies to achieve this in real-world practice. This review outlines the role that inflammation plays in atherosclerosis and provides an update on anti-inflammatory therapies currently being investigated to target atherosclerosis." @default.
- W2964952983 created "2019-08-13" @default.
- W2964952983 creator A5005228563 @default.
- W2964952983 creator A5046802621 @default.
- W2964952983 creator A5066016421 @default.
- W2964952983 creator A5083347645 @default.
- W2964952983 creator A5084209883 @default.
- W2964952983 creator A5085190525 @default.
- W2964952983 date "2019-07-26" @default.
- W2964952983 modified "2023-10-17" @default.
- W2964952983 title "Inflammation as a Therapeutic Target in Atherosclerosis" @default.
- W2964952983 cites W1153335416 @default.
- W2964952983 cites W1520609538 @default.
- W2964952983 cites W1705607911 @default.
- W2964952983 cites W1749239599 @default.
- W2964952983 cites W1792593929 @default.
- W2964952983 cites W1812416290 @default.
- W2964952983 cites W1876046294 @default.
- W2964952983 cites W1942793553 @default.
- W2964952983 cites W1961466730 @default.
- W2964952983 cites W1964064254 @default.
- W2964952983 cites W1970295969 @default.
- W2964952983 cites W1971308765 @default.
- W2964952983 cites W1972483153 @default.
- W2964952983 cites W1972919038 @default.
- W2964952983 cites W1980756397 @default.
- W2964952983 cites W1984797067 @default.
- W2964952983 cites W1993510043 @default.
- W2964952983 cites W1996203160 @default.
- W2964952983 cites W2009800174 @default.
- W2964952983 cites W2014266615 @default.
- W2964952983 cites W2015230474 @default.
- W2964952983 cites W2015410646 @default.
- W2964952983 cites W2028545985 @default.
- W2964952983 cites W2032485049 @default.
- W2964952983 cites W2033896075 @default.
- W2964952983 cites W2037371398 @default.
- W2964952983 cites W2048032544 @default.
- W2964952983 cites W2048083630 @default.
- W2964952983 cites W2052617165 @default.
- W2964952983 cites W2058312167 @default.
- W2964952983 cites W2058610272 @default.
- W2964952983 cites W2061870298 @default.
- W2964952983 cites W2067504868 @default.
- W2964952983 cites W2068985697 @default.
- W2964952983 cites W2071568768 @default.
- W2964952983 cites W2072005929 @default.
- W2964952983 cites W2072117604 @default.
- W2964952983 cites W2072453475 @default.
- W2964952983 cites W2074954748 @default.
- W2964952983 cites W2084001707 @default.
- W2964952983 cites W2085453879 @default.
- W2964952983 cites W2094941678 @default.
- W2964952983 cites W2100709790 @default.
- W2964952983 cites W2100748836 @default.
- W2964952983 cites W2101139377 @default.
- W2964952983 cites W2105582360 @default.
- W2964952983 cites W2110833991 @default.
- W2964952983 cites W2113187337 @default.
- W2964952983 cites W2113978145 @default.
- W2964952983 cites W2114215066 @default.
- W2964952983 cites W2115004354 @default.
- W2964952983 cites W2116592902 @default.
- W2964952983 cites W2118154631 @default.
- W2964952983 cites W2119358571 @default.
- W2964952983 cites W2121021320 @default.
- W2964952983 cites W2123082894 @default.
- W2964952983 cites W2126894693 @default.
- W2964952983 cites W2127469535 @default.
- W2964952983 cites W2128383347 @default.
- W2964952983 cites W2128455103 @default.
- W2964952983 cites W2129271736 @default.
- W2964952983 cites W2133654459 @default.
- W2964952983 cites W2137983259 @default.
- W2964952983 cites W2138809584 @default.
- W2964952983 cites W2139957955 @default.
- W2964952983 cites W2143727405 @default.
- W2964952983 cites W2145634137 @default.
- W2964952983 cites W2147155927 @default.
- W2964952983 cites W2149858388 @default.
- W2964952983 cites W2150637250 @default.
- W2964952983 cites W2151279508 @default.
- W2964952983 cites W2151729372 @default.
- W2964952983 cites W2154109643 @default.
- W2964952983 cites W2154461664 @default.
- W2964952983 cites W2155123856 @default.
- W2964952983 cites W2155615329 @default.
- W2964952983 cites W2159449551 @default.
- W2964952983 cites W2159513257 @default.
- W2964952983 cites W2160427887 @default.
- W2964952983 cites W2161465441 @default.
- W2964952983 cites W2163553356 @default.
- W2964952983 cites W2163684054 @default.
- W2964952983 cites W2164189703 @default.
- W2964952983 cites W2165463540 @default.
- W2964952983 cites W2167939282 @default.
- W2964952983 cites W2169252817 @default.
- W2964952983 cites W2228363580 @default.